Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01XXN
|
|||
Former ID |
DNC004122
|
|||
Drug Name |
N-Hydroxy-4-phenylacetylamino-benzamide
|
|||
Synonyms |
CHEMBL356824; 656261-23-3; SCHEMBL675578; CTK1J6158; DTXSID40458440; ZINC13533297; AKOS030583151; Benzeneacetamide, N-[4-[(hydroxyamino)carbonyl]phenyl]-
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H14N2O3
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CC(=O)NC2=CC=C(C=C2)C(=O)NO
|
|||
InChI |
1S/C15H14N2O3/c18-14(10-11-4-2-1-3-5-11)16-13-8-6-12(7-9-13)15(19)17-20/h1-9,20H,10H2,(H,16,18)(H,17,19)
|
|||
InChIKey |
VQGKLYBEQDAOSV-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 656261-23-3
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. J Med Chem. 2005 Aug 25;48(17):5530-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.